The toxicological mode of action and the safety of synthetic amorphous silica-A nanostructured material

Toxicology

Volumn 294, Issue 2-3, 2012, Pages 61-79

  Fruijtier Pölloth, Claudia ^a  

^a CATS Consultants GmbH   (Germany)

Author keywords

Mode of action; Nano object; Nanoparticle; Nanosilica; Nanostructured; Synthetic amorphous silica

Indexed keywords

CELL MEMBRANE MARKER; COSMETIC; CYTOKINE; HYDROGEN; LIPID; NANOMATERIAL; REACTIVE OXYGEN METABOLITE; SILICON DIOXIDE; SYNTHETIC SILICON DIOXIDE; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ALGA; BACTERICIDAL ACTIVITY; BACTERIUM; BIOLOGICAL ACTIVITY; BLOOD TOXICITY; CARCINOGENIC ACTIVITY; CARCINOGENICITY; CELL MEMBRANE POTENTIAL; CELL STRUCTURE; CELL SURFACE; CELL TYPE; CHEMICAL REACTION; CHEMICAL STRUCTURE; CHRONIC TOXICITY; CLEARANCE; COLLOID; COSMETIC INDUSTRY; COVALENT BOND; CYTOKINE RELEASE; CYTOTOXICITY; DISPERSION; DISSOLUTION; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG INDUSTRY; ECOTOXICITY; ENDOSOME; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL IMPACT; FISH; FOOD INDUSTRY; GEL; GENE EXPRESSION; GENE MUTATION; GENOTOXICITY; HEALTH HAZARD; HUMAN; HYDROGEN BOND; INDUSTRIAL HYGIENE; INFLAMMATION; INTRACELLULAR SIGNALING; LIPID PEROXIDATION; LUNG TOXICITY; MOLECULAR SIZE; MUSSEL; NANOFABRICATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PARTICLE SIZE; PATHOPHYSIOLOGY; PHYSICAL CHEMISTRY; PNEUMONIA; PRIORITY JOURNAL; REACTION TIME; REPRODUCTIVE TOXICITY; REVIEW; SKIN IRRITATION; SKIN SENSITIZATION; SOLUBILITY; STANDARDIZATION; TERATOGENICITY; TOXICITY TESTING; YEAST;

ANIMALS; CELL MEMBRANE; CHEMOKINES; COLLOIDS; CYTOKINES; HUMANS; INFLAMMATION; NANOPARTICLES; PARTICLE SIZE; REACTIVE OXYGEN SPECIES; SILICON DIOXIDE; SURFACE PROPERTIES;

EID: 84858998451     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2012.02.001     Document Type: Review

References (123)

1. 2, and ZnO water suspensions. Water Res. 2006, 40:3527-3532.
2. Alexander G.B., Heston W.M., Iler R.K. The solubility of amorphous silica in water. J. Phys. Chem. 1954, 58:453-455.
3. 2 particles in HeLa cells. Arch. Toxicol. 2011, 85:813-826.
4. Arts J.H., Muijser H., Duistermaat E., Junker K., Kuper C.F. Five-day inhalation toxicity study of three types of synthetic amorphous silicas in Wistar rats and post-exposure evaluations for up to 3 months. Food Chem. Toxicol. 2007, 45:1856-1867.
5. Arts J.H., Schijf M.A., Kuper C.F. Preexposure to amorphous silica particles attenuates but also enhances allergic reactions in trimellitic anhydride sensitized Brown Norway rats. Inhal. Toxicol. 2008, 20:935-948.
6. Barnes C.A., Elsaesser A., Arkusz J., Smok A., Palus J., Lesniak A., Salvati A., Hanrahan J.P., de Jong W.H., Dziubałtowska E., Stepnik M., Rydzyńsk K., McKerr G., Lynch I., Dawson K.A., Howard C.V. Reproducible comet assay of amorphous silica nanoparticles detects no genotoxicity. Nano Lett. 2008, 8:3069-3074.
7. Becker, L.C., Bergfeld, W.F., Belsito, D.V., Hill, R.A., Klaassen, C.D., Liebler, D.C., Marks Jr., J.G., Shank, R.C., Slaga, T.J., Snyder, P.W., 2009. Safety assessment of silica and related cosmetic ingredients. Washington, DC, USA, Cosmetic Ingredient Review. Unpublished Report by the Cosmetic Ingredient Review, pp. 1-81.
8. Böl, G.F., Epp, A., Hertel, R. (Eds.), 2010. Wahrnehmung der Nanotechnologie in internetgestützten Diskussionen-Ergebnisse einer Onlinediskursanalyse zu Risiken und Chancen von Nanotechnologie und Nanoprodukten. Bundesinstitut für Risikobewertung, Berlin, ISBN 3-938163-57-7, ISSN 1614-3795 (in German).
9. Borm P.J.A., Schins R., Albrecht C. Inhaled particles and lung cancer. Part B: paradigms and risk assessment. Int. J. Cancer 2004, 110:3-14.
10. Borm P., Robbins D., Haubold S., Kuhlbusch T., Fissau H., Donaldson K., Schinis R., Stone V., Kreyling W., Lademann J., Krutmann J., Warheit D., Oberdorster E. The potential risks of nanomaterials: a review carried out for ECETOC. Particle Fiber Toxicol. 2006, 3:11. 10.1186/1743-8977-3-11.
11. Borm P., Klaessig F.C., Landry T.D., Moudgil B., Pauluhn J., Thomas K., Trottier R., Wood S. Research strategies for safety evaluation of nanomaterials. Part V: role of dissolution in biological fate and effects of nanoscale particles. Toxicol. Sci. 2006, 90:23-32.
12. Bosch A., Maier M., Morfeld P. Nanosilica? Clarifications are necessary!. Nanotoxicology 2011, 1-3. (Early Online).
13. BREF, 2007. Best Available Techniques Reference Document. Integrated Pollution Prevention and Control. Reference Document on Best Available Techniques for the Manufacture of Large Volume Inorganic Chemicals-Solids and Others industry. Chapter 5: Synthetic Amorphous Silica. European Commission, August 2007.
14. Brunner T.J., Wick P., Manser P., Spohn Ph Grass R.N., Limbach L.K., Bruinink A., Stark W.J. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ. Sci. Technol. 2006, 40:4374-4381.
15. 2) on Mytilus hemocytes. Aquat. Toxicol. 2010, 96:151-158.
16. Chang J.S., Chang K.L., Hwang D.F., Kong Z.L. In vitro cytotoxicitiy of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. Environ. Sci. Technol. 2007, 41:2064-2068.
17. 2 nanoparticles. Exp. Cell Res. 2005, 305:51-62.
18. Chen Y., Chen J., Dong J., Jin Y. Comparing study of the effect of nanosized silicon dioxide and microsized silicon dioxide on fibrogenesis in rats. Toxicol. Ind. Health 2004, 20:21-27.
19. 2 nanoparticle inhalation: nanotoxicity has susceptible population. Environ. Sci. Technol. 2008, 42:8985-8992.
20. Cho W.S., Choi M., Han B.S., Cho M., Oh J., Park K., Kim S.J., Kim S.H., Jeong J. Inflammatory mediators induced by intratracheal instillation of ultrafine amorphous silica particles. Toxicol. Lett. 2007, 175:24-33.
21. Cho M., Cho W.S., Choi M., Kim S.J., Han B.S., Kim S.H., Kim H.O., Sheen Y.Y., Jeong J. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol. Lett. 2009, 189:177-183.
22. Chuiko A.A. Medicinal Chemistry and Clinical Application of Silicon Dioxide 2003, Nukova Dumka, Kiev.
23. Chung T.H., Wu S.H., Yao M., Lu C.W., Lin Y.S., Hung Y., Mou C.Y., Chen Y.C., Huang D.M. The effects of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomat. 2007, 28:2959-2966.
24. Costantini L.M., Gilberti R.M., Knecht D.A. The phagocytosis and toxicity of amorphous silica. PLoS ONE 2011, 6:e14647. 10.1371/journal.pone.0014647.
25. Dekkers S., Krystek P., Peters R.J.B., Lankveld D.P.K., Bokkers B.G.H., van Hoeven-Arentzen P.H., Bouwmeester H., Oomen A.G. Presence and risks of nanosilica in food products. Nanotoxicology 2010, 13. 10.3109/17435390.2010.519836.
26. Depasse J., Watillon A. The stability of amorphous colloidal silica. J. Colloid Interface Sci. 1970, 33:430-438.
27. Donaldson K., Borm P.J.A., Oberdörster G., Pinkerton K.E., Stone V., Tran C.L. Concordance between in vitro and in vivo dosimetry in the proinflammatory effects of low-toxicity, low-solubility particles: the key role of the proximal alveolar region. Inhal. Toxicol. 2008, 20:53-62.
28. Drescher D., Orts-Gil G., Laibe G., Natte K., Veh R.W., österle W., Kneipp J. Toxicity of amorphous silica nanoparticles on eukaryotic cell model is determined by particle agglomeration and serum protein adsorption effects. Anal. Bioanal. Chem. 2011, 400:1367-1373.
29. Dutta D., Sundaran S.K., Teeguarden J.G., Riley B.J., Fifield L.S., Jacobs J.M., Addleman S.R., Kaysen G.A., Moudgil B.M., Weber T.J. Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol. Sci. 2007, 100:303-315.
30. ECETOC, 2006. European Centre for Ecotoxicology and Toxicology of Chemicals. Synthetic Amorphous Silica (CAS No. 7631-86-9). JACC No. 51. Brussels, 237 pp.
31. EFSA (European Food Safety Authority) Scientific opinion of the panel on food additives and nutrient sources added to food on calcium silicate, silicon dioxide and silicic acid gel added for nutritional purposes to food supplements following a request from the European Commission. EFSA J. 2009, 1132:1-24.
32. Eom H.J., Choi J. Oxidative stress of silica nanoparticles in human bronchial epithelial cell, Beas-2B. Toxicol. In Vitro 2009, 23:1326-1332.
33. EPA, 2011. U.S. Environmental Protection Agency. Screening-Level Hazard Characterization of Silane, Dichlorodimethyl-, Reaction Product with Silica (CASRN 68611-44-9), June 2011.
34. Farré M., Gajda-Schrants K., Kantiani L., Barce D. Ecotoxicity and analysis of nanomaterials in the aquatic environment. Anal. Bioanal. Chem. 2009, 393:81-95.
35. FDA, 1973. Food and Drug Research Laboratories, Inc. Teratologic Evaluation of FDA 71-48 (Syloid; silica aerogel). Reports prepared under DEW Contract No. FDA 71-260. Maspeth NW, 56 pp.
36. Fujiwara K., Suematsu H., Aoki M., Sato M., Nobuko M. Size dependent toxicity of silica nanoparticles to Chlorella kessleri. J. Environ. Sci. Health Part A 2008, 43:1167-1173.
37. 2 nanoparticles to the yeast, Saccharomyces cerevisiae. J. Hazard Mat. 2011, 192:1572-1579.
38. Gonzalez L., Thomassen L.C.J., Plas G., Rabolli V., Napierska D., Decordier I., Roelants M., Hoet P.H., Kirschhock C.E.A., Martens J.A., Lison D., Kirsch-Volders M. Exploring the aneugenic and clastogenic potential in the nanosize range: A549 human lung carcinoma cells and amorphous monodisperse silica nanoparticles as models. Nanotoxicology 2010, 4:382-395.
39. Gray C.A., Muranko H. Studies of robustness of industrial aciniform aggregates and agglomerates-carbon black and amorphous silica: a review amplified by new data. J. Occupational Environ. Med. 2006, 48:1279-1290.
40. Hainfeld J.F., Slatkin D.N., Focella T.M., Smilowitz H.M. Gold nanoparticles: a new X-ray contrast agent. Br. J. Radiol. 2006, 79:248-253.
41. Hamilton R.F., Thakur S.A., Holian A. Silica binding and toxicity in alveolar macrophages. Free Radic. Biol. Med. 2008, 44:1246-1258.
42. Holleman-Wiberg Lehrbuch der Anorganischen Chemie 2008, De Gruyter, Berlin, [in German].
43. Hudson S., Padera R.F., Langer R., Kohane D.S. The biocompatibility of mesoporous silicates. Biomaterials 2008, 29(30):4045-4055.
44. IARC, 1997. International Agency on the Research of Cancer. Working Group on the Evaluation of Carcinogenic Risks to Humans. Silica, some silicates, coal dust and para-aramid fibrils, vol. 68, 1-475.
45. ISO, 2008. The International Organisation for Standardisation. Nanotechnologies-Terminology and definitions for nano-objects-Nanoparticle, nanofibre and nanoplate. ISO/TS 27687 (will be revised as ISO/TS 80004-2).
46. ISO, 2010. The International Organisation for Standardisation. Nanotechnologies-Vocabulary-Part 1: Core Terms. ISO/TS 80004-1.
47. Isoda K., Hasezaki T., Kondoh M., Tsutsumi Y., Yagi K. Effect of surface charge on nano-sized silica particles-induced liver injury. Pharmazie 2011, 66:278-281.
48. Ji J., Long Z., Lin D. Toxicity of oxide nanoparticles to the green algae Chlorella sp. Chem. Eng. J. 2011, 170:525-530.
49. Jiang W., Mashayekhi H., Xing B. Bacterial toxicity comparison between nano- and micro-sized oxide particles. Environ. Pollut. 2009, 157:1619-1625.
50. Johnston C.J., Driscoll K.E., Finkelstein J.N., Baggs R., O'Reilly M.A., Carter J., Gelein R., Oberdorster G. Pulmonary chemokine and mutagenic responses in rats after subchronic inhalation of amorphous and crystalline silica. Toxicol. Sci. 2000, 56:405-413.
51. Kaewamatawong T., Kawamura N., Okajima M., Sawada M., Morita T., Shimada A. Acute pulmonary toxicity caused by exposure to colloidal silica: particle size dependent pathological changes in mice. Toxicol. Pathol. 2005, 33:743-749.
52. Kaewamatawong T., Shimada A., Okajima M., Inoue H., Morita T., Inoue K., Takano H. Acute and subacute pulmonary toxicity of low dose of ultrafine colloidal silica particles in mice after intratracheal instillation. Toxicol. Pathol. 2006, 34:958-965.
53. Kim H.W., Ahn E.K., Jee B.K., Yoon H.K., Lee K.H., Lim Y. Nanoparticulate-induced toxicity and related mechanism in vitro and in vivo. J. Nanopart. Res. 2009, 11:55-65.
54. Kim Y.J., Yu M., Park H.O., Yang S.I. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by silica nanomaterials in human neuronal cell line. Mol. Cell Toxicol. 2010, 6:337-344.
55. Klimisch H.J., Andreae E., Tillmann U. A systematic approach for evaluating the quality of experimental and ecotoxicological data. Reg. Tox. Pharm. 1997, 25:1-5.
56. Kolling A., Ernst H., Rittinghausen S., Heinrich U. Relationship of pulmonary toxicity and carcinogenicity of fine and ultrafine granular dusts in a rat bioassay. Inhal. Toxicol. 2011, 23:544-554.
57. Krombach F., Münzing S., Allmeling A.M., Gerlach J.T., Behr J., Droger M. Cell size of alveolar macrophages: an interspecies comparison. Environ. Health Perspect. 1997, 105(Suppl. 5):1261-1263.
58. Lee K.P., Kelly D.P. The pulmonary response and clearance of Ludox colloidal silica after a 4-week inhalation exposure in rats. Fundam. Appl. Toxicol. 1992, 19:399-410.
59. Lee S.W., Kim S.M., Choi J. Genotoxicity and ecotoxicity assays using the freshwater crustacean Daphnia Magna and the larva of the aquatic midge Chironomus riparius to screen the ecological risks of nanoparticle exposure. Environ. Tax. Pharm. 2009, 28:86-91.
60. Lewinson J., Mayr W., Wagner H. Characterization and toxicological behavior of synthetic amorphous hydrophobic silica. Regul. Toxicol. Pharmacol. 1994, 20(1):37-57.
61. Limbach L.K., Wick P., Manser P., Grass R.N., Bruinink A., Stark W.J. Exposure of engineered nanoparticles to human lung epithelial cells: influence of chemical composition and catalytic activity on oxidative stress. Environ. Sci. Technol. 2007, 41:4158-4163.
62. Lin W., Huang Y.W., Zhou X.D., Ma Y. In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol. Appl. Pharmacol. 2006, 217:252-259.
63. Lison D., Thomassen L.C.J., Rabolli V., Gonzalez L., Napierska D., Seo J.W., Kirsch-Volders M., Hoet P., Kirschhock C.E.A., Martens J.A. Nominal and effective dosimetry of silica nanoparticles in cytotoxicity assays. Toxicol. Sci. 2008, 104:155-162.
64. Liu X., Keane M.J., Zhong B.Z., Ong T., Wallace W.E. Micronucleus formation in V79 cells treated with respirable silica dispersed in medium and in simulated pulmonary surfactant. Mut. Res. 1996, 361:89-94.
65. Lu F., Wu S.H., Hung Y., Mou C.Y. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small 2009, 5:1408-1413.
66. Ma-Hock L., Gamer A.O., Landsiedel R., Leibold E., Frechen T., Sens B., Linsenbuehler M., van Ravenzwaay B. Generation and characterization of test atmospheres with nanomaterials. Inhal. Toxicol. 2007, 19:833-848.
67. Maier M., Hannebauer B., Holldorff H., Albers P. Does lung surfactant promote disaggregation of nanostructured titanium dioxide?. J. Occupational Environ. Med. 2006, 48:1314-1320.
68. McLaughlin J.K., Chow W.H., Levy L.S. Amorphous silica: a review of health effects from inhalation exposure with particular reference to cancer. J. Toxicol. Environ. Health 1997, 50:553-566.
69. Meek, M.E., 2009. Mode of Action Frameworks in Toxicity Testing and Chemical Risk Assessment. Ph.D. Thesis. Institute for Risk Assessment Sciences (IRAS), Utrecht University, the Netherlands. ISBN: 978-90-393-51505.
70. Merget R., Bauer T., Kupper H.U., Philippou S., Bauer H.D., Breitstadt R., Bruening T. Health hazards due to the inhalation of amorphous silica. Arch. Toxicol. 2002, 15:625-634.
71. Morfeld P., Albrecht C., Drommer W., Borm P.J.A. Dose-response and threshold analysis of tumor prevalence after intratracheal instillation of six types of low- and high-surface-area particles in a chronic rat experiment. Inhal. Toxicol. 2006, 18:215-225.
72. Mou C.Y., Lin H.P. Control of morphology in synthesizing mesoporous silica. Pure Appl. Chem. 2000, 72(1-2):137-146.
73. Nabeshi H., Yoshikawa T., Matsuyama K., Nakazato Y., Arimori A., Isobe M., Tochigi S., Kondoh S., Hirai T., Akase T., Yamashita T., Yamashita K., Yoshida T., Nagano K., Abe Y., Yoshioka Y., Kamada H., Imazawa T., Itoh N., Tsunoda S., Tsutsumi Y. Size-dependent cytotoxic effects of amorphous silica nanoparticles on Langerhans cells. Pharmazie 2010, 65:199-201.
74. Napierska D., Thomassen L.C.J., Lison D., Martens J.A., Hoet P.H. The nanosilica hazard: another variable entity. Part. Fibre Toxicol. 2010, 7:39.
75. Nash T., Allison A.C., Harington J.S. Physicochemical properties of silica in relation to its toxicity. Nature 1966, 211:259-261.
76. Nel A., Xia T., Mädler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311(5761):622-627.
77. Nelson S.M., Mahmoud T., Beaux M., Shapiro P., McIlroy D.N., Stenkamp D.L. Toxic and teratogenic siica nanowires in developing vertebrate embryos. Nanomed.: Nanotechn. Biol. Med. 2010, 6:93-102.
78. Nishimori H., Kondoh M., Isoda K., Tsunoda S., Tsutsumi Y., Yagi K. Silica nanoparticles as hepatotoxicants. Eur. J. Pharm. Biopharm. 2009, 72:496-501.
79. Nowack B., Bucheli T.D. Occurrence, behaviour and effects of nanoparticles in the environment. Environ. Poll. 2007, 150:5-22.
80. OECD, 2004. Organisation for Economic Co-operation and Development. SIDS Dossier on Synthetic Amorphous Silica and Silicates. October 2004.
81. OECD, 2005. Organisation for Economic Co-operation and Development. Manual for Investigation of HPV Chemicals. Chapter 3: Data Evaluation. Guidance for Determining the Quality of Data for the SIDS Dossier: Reliability, Relevance and Adequacy.
82. O'Farrell N., Houtton A., Horrocks B.R. Silicon nanoparticles: application in cell biology and medicine. Int. J. Nanomed. 2006, 1:451-472.
83. O'Reilly K.M.A., Phipps R.P., Thatcher T.H., Graf B.A., van Kirk J., Sime P.J. Crystalline and amorphous silica differentially regulate the cyclooxygenase-prostaglandin pathway in pulmonary fibroblasts: implication for pulmoary fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 2005, 288:L1010-L1016.
84. Orr G., Panther D.J., Cassens K.J., Phillips J.L., Tarasevich B.J., Pounds J.G. Syndecan-1 mediates the coupling of positively charged submicrometer amorphous silica particles with actin filaments across the alveolar epithelial cell membrane. Toxicol. Appl. Pharmacol. 2009, 236:210-220.
85. Pacheco, S.E., Mashayekhi, H., Jiang, W., Xing, B., Arcaro, K.F., 2007. DNA damaging effects of nanoparticles in breast cancer cells. Abstracts of the 2007 Annual Meeting of the American Association for Cancer Research (As cited by Barnes et al., 2008).
86. Pandurangi R.S., Seehra M.S., Razzaboni B.L., Bolsaitis P. Surface and bulk infrared modes of crystalline and amorphorous silica particles: a study of the relation of surface structure to cytotoxicity of respirable silica. Environ. Health Perspect. 1990, 86:327-336.
87. Park E.J., Park K. Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro. Toxicol. Lett. 2009, 184:18-25.
88. Park M.V.D.Z., Verharen H.W., Zwart E., Hernandez L.Y.A.G., van Benthem J., Elsaesser A., Barnes C., McKerr G., Howard C.V., Salvati A., Lynch I., Dawson K.A., De Jong W.H. Genotoxicity evaluation of amorphous silica nanoparticles of different sizes using the micronucleus and the plasmid lacZ gene mutation assay Nanotoxicol. Early Online 2010, 1-14.
89. Park Y.H., Kim J.N., Jeong S.H., Choi J.E., Lee S.H., Choi B.H., Lee J.P., Sohn K.H., ParkK.L.Kim M.K., Son S.W. Assessment of dermal toxicity of nanosilica using cultured keratinocytes, a human skin equivalent model and an in vivo model. Toxicology 2010, 267:178-181.
90. Peters K., Unger R.E., Kirkpatrick C.J., Gatti A.M., Monari E. Effects of nano-scaled particles on endothelial cell function in vitro: studies on viability, proliferation, and inflammation. J. Mater. Sci. Mater. Med. 2004, 15:321-325.
91. Ravi Kumar M.N.V., Sameti M., Mohapatra S.S., Kong X., Lockey R.F., Bakowsky U., Lindenblatt G., Schmidt C.H., Lehr C.M. J. Nanosci. Nanotechnol. 2004, 4:876-881.
92. 2 nanoparticles from nanocomposites. Polymer Degrad. Stab. 2009, 94:873-876.
93. Reuzel P.G.J., Bruijntjes J.P., Feron V.J., Woutersen R.A. Subchronic inhalation toxicity of amorphous silicas and quartz dust in rats. Food Chem. Toxicol. 1991, 29:341-354.
94. Roelofs F., Vogelsberger W. Dissolution kinetics of synthetic amorphous silica in biological-like media and its theoretical description. J. Phys. Chem. B 2004, 108:11308-11316.
95. Sayes C.M., Reed K.I., Warheit D.B. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol. Sci. 2007, 97:163-180.
96. Sayes C.M., Reed K.L., Glover K.P., Swain K.A., Ostraat M.L., Donner E.M., Warheit D.B. Changing the dose metric for inhalation toxicity studies: short-term study in rats with engineered aerosolized amorphous silica nanoparticles. Inhal. Toxicol. 2010, 22:348-354.
97. Shapero K., Fenaroli F., Lynch I., Cottell D.C., Salvati A., Dawson K.A. Time and space resolved uptake study of silica nanoparticles by human cells. Mol. Biosyst. 2011, 7:371-378.
98. Singal, M., 2010. Nanoparticle Induced Inflammatory Signaling in the Lung. Mechanism of Aerosil200 Particulate Induced Inflammatoy Gene Expression in Alveolar Epithelial Cells. VDM Verlag Dr. Müller. ISBN 978-3-639-21552-6.
99. Singal M., Finkelstein J. Amorphous silica particles promote inflammatory gene expression through the redox sensitive transcription factor, AP-1, in alveolar epithelial cells. Exp. Lung Res. 2005, 31:581-597.
100. Slowing I.I., Wu C.W., Vivero-Escoto J.L., Lin V.S. Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small 2009, 5:57-62.
101. Slowing I., Vivero-Escoto J.L., Zhao Y., Kandel K., Peeraphaldit C., Trewyn B.G., Lin V.S. Exocytosis of mesoporous silica nanoparticles from mammalian cells: from asymmetric cell-to-cell transfer to protein harvesting. Small 2011, 7:1526-1532.
102. So S.J., Jang I.S., Han C.S. Effect of micro/nano silica particle feeding for mice. J. Nanosci. Nanotechnol. 2008, 8:5367-5371.
103. Stintz, M., 2001. Particle analysis of pyrogenic (fumed) silicas at technical concentrations and under technical handling conditions. Techn. Univ. Dresden, Inst. f. Verfahrenstechn. (20 January 2001 as cited by OECD (2004)).
104. Stöber W., Fink W., Bohn E. Controlled growth of monodisperse silica spheres in the micron size range. J. Colloid Interface Sci. 1968, 26:62-69.
105. Stöber, W., Wong, B., Koch, W., Windt, H., 2000. A simple pulmonary retention model for inhaled soluble particles of limited biological residence time. Report by CIIT, Research Triangle Park, USA and Fraunhofer-Institut, Hannover, Germany. 30 June 2000. Study sponsored by CEFIC/ASASP, Brussels, Belgium.
106. Takizawa Y., Hirasawa F., Noritomi E., Aida M., Tsunoda H., Uesugi S. Oral ingestion of Syloid to mice and rats and its chronic toxicity and carcinogenicity. Acta Med. Biol. 1988, 36:27-56.
107. Teeguarden J.G., Hinderliter P.M., Orr G., Thrall B.D., Pounds J.G. Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol. Sci. 2007, 95:300-312.
108. Valberg P.A., Bruch J., McCunney R.J. Are rat results from intratracheal instillation of 19 granular dusts a reliable basis for predicting cancer risk?. Regul. Toxicol. Pharmacol. 2009, 54:72-83.
109. van Hoecke K., De Schamphelaere K.A.C., Van der Meeren P., Lucas S., Janssen C.R. Ecotoxicity of silica nanoparticles to the green alga pseudokirchnerie/la subcapitata: importance of surface area. Environ. Tox. Chem. 2008, 27:1948-1957.
110. 2 nanoparticles in algal growth inhibition assays at various pH and organic matter contents. Environ. Int. 2011, 37:1118-1125.
111. Vogelsberger, W., 1999. Some results of dissolution experiments carried out with different kinds of amorphous silica. CEFIC/ASASP Report 1999 as cited in OECD (2004).
112. Volkheimer G. Passage of particles through the wall of the gastrointestinal tract. Environ. Health Perspect. 1974, 9:215-225.
113. Warheit D.B., Carakostas M.C., Kelly D.P., Hartsky M.A. Four-week inhalation toxicity study with Ludox colloidal silica in rats: pulmonary cellular responses. Fundam. Appl. Toxicol. 1991, 16:590-601.
114. Warheit D.B., McHugh T.A., Hartsky M.A. Differential pulmonary responses in rats inhaling crystalline, colloidal or amorphous silica dusts. Scand. J. Work Environ. Health 1995, 21(Suppl. 2):19-21.
115. Wei C., Zhang Y., Guo J., Han B., Yang X., Yuan J. Effects of silica nanoparticles on growth and photosynthetic pigmaent contents of Scenedesmus obliquus. J. Environ. Sci. 2010, 22:155-160.
116. Xue Z.G., Zhu S.H., Pan Q., Liang D.S., Li Y.M., Liu X.H., Xia J.H. Biotoxicology and biodynamics of silica nanoparticle. J. Central South Univ. Med. Sci. 2006, 31:6-8. (in Chinese).
117. Yang H., Liu C., Yang D., Zhang H., Xi Z. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J. Appl. Toxicol. 2009, 29:69-78.
118. Yang K., Lin D., Xing B. Interactions of humic acid with nanosized inorganic oxides. Langmuir 2009, 25:3571-3576.
119. 2 nanoparticles induce cytotoxicity and protein expression alteration in HaCaT cells. Part Fibre Toxicol. 2010, 7:1.
120. Ye Y., Liu J., Chen M., Sun L., Lan M. In vitro toxicity of silica nanoparticles in myocardial cells. Environ. Toxicol. Pharmacol. 2010, 29:131-137.
121. 2 induces apoptosis via activation of p53 and Bax mediated by oxidative stress in human hepatic cell line. Toxicol. In Vitro 2010, 24:751-758.
122. Yu K.O., Grabinski C.M., Schrand A.M., Murdock R.C., Wang W., Gu B., Schlager J.J., Hussain S.M. Toxicity of amorphous silica nanoparticles in mouse keratinocytes. J. Nanopart. Res. 2009, 11:15-24.
123. Zhong B.Z., Whong W.Z., Ong T.M. Detection of mineral-dust-induced DNA damage in two mammalian cell lines using the alkaline single cell gel comet assay. Mutat. Res. 1997, 393:181-187.